FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:PTPRU-C10orf76

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: PTPRU-C10orf76
FusionPDB ID: 70568
FusionGDB2.0 ID: 70568
HgeneTgene
Gene symbol

PTPRU

C10orf76

Gene ID

10076

79591

Gene nameprotein tyrosine phosphatase receptor type Uarmadillo like helical domain containing 3
SynonymsFMI|PCP-2|PTP|PTP-J|PTP-PI|PTP-RO|PTPPSI|PTPRO|PTPU2|R-PTP-PSI|R-PTP-U|hPTP-JC10orf76
Cytomap

1p35.3

10q24.32

Type of geneprotein-codingprotein-coding
Descriptionreceptor-type tyrosine-protein phosphatase UPTP piReceptor protein tyrosine phosphatase hPTP-Jpancreatic carcinoma phosphatase 2pi R-PTP-Psiprotein-tyrosine phosphatase Jprotein-tyrosine phosphatase piprotein-tyrosine phosphatase receptor omicronrarmadillo-like helical domain-containing protein 3UPF0668 protein C10orf76
Modification date2020031320200313
UniProtAcc..
Ensembl transtripts involved in fusion geneENST idsENST00000323874, ENST00000345512, 
ENST00000356870, ENST00000373779, 
ENST00000428026, ENST00000460170, 
ENST00000415600, 
ENST00000311122, 
ENST00000495001, ENST00000370033, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score8 X 6 X 7=3368 X 6 X 5=240
# samples 109
** MAII scorelog2(10/336*10)=-1.74846123300404
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(9/240*10)=-1.41503749927884
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Fusion gene context

PubMed: PTPRU [Title/Abstract] AND C10orf76 [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: PTPRU [Title/Abstract] AND C10orf76 [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)PTPRU(29587415)-C10orf76(103699695), # samples:1
Anticipated loss of major functional domain due to fusion event.PTPRU-C10orf76 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
PTPRU-C10orf76 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
PTPRU-C10orf76 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
PTPRU-C10orf76 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
HgenePTPRU

GO:0006470

protein dephosphorylation

12501215

HgenePTPRU

GO:0008285

negative regulation of cell proliferation

16574648

HgenePTPRU

GO:0030336

negative regulation of cell migration

12501215|16574648

HgenePTPRU

GO:0034394

protein localization to cell surface

16574648

HgenePTPRU

GO:0090090

negative regulation of canonical Wnt signaling pathway

16574648

HgenePTPRU

GO:2000049

positive regulation of cell-cell adhesion mediated by cadherin

16574648



check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr1:29587415/chr10:103699695)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across PTPRU (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across C10orf76 (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000345512PTPRUchr129587415+ENST00000370033C10orf76chr10103699695-356712731291637502
ENST00000373779PTPRUchr129587415+ENST00000370033C10orf76chr10103699695-356712731291637502
ENST00000356870PTPRUchr129587415+ENST00000370033C10orf76chr10103699695-354812541101618502
ENST00000323874PTPRUchr129587415+ENST00000370033C10orf76chr10103699695-354812541101618502
ENST00000428026PTPRUchr129587415+ENST00000370033C10orf76chr10103699695-35341240961604502
ENST00000460170PTPRUchr129587415+ENST00000370033C10orf76chr10103699695-3444115061514502

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000345512ENST00000370033PTPRUchr129587415+C10orf76chr10103699695-0.0062523830.9937476
ENST00000373779ENST00000370033PTPRUchr129587415+C10orf76chr10103699695-0.0062523830.9937476
ENST00000356870ENST00000370033PTPRUchr129587415+C10orf76chr10103699695-0.0063830350.99361694
ENST00000323874ENST00000370033PTPRUchr129587415+C10orf76chr10103699695-0.0063830350.99361694
ENST00000428026ENST00000370033PTPRUchr129587415+C10orf76chr10103699695-0.0062327920.99376726
ENST00000460170ENST00000370033PTPRUchr129587415+C10orf76chr10103699695-0.0053138920.9946861

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for PTPRU-C10orf76

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
PTPRUchr129587415C10orf76chr101036996951150380GRPGPPLISRTKCAVLRLSTNAGQWK
PTPRUchr129587415C10orf76chr101036996951240380GRPGPPLISRTKCAVLRLSTNAGQWK
PTPRUchr129587415C10orf76chr101036996951254380GRPGPPLISRTKCAVLRLSTNAGQWK
PTPRUchr129587415C10orf76chr101036996951273380GRPGPPLISRTKCAVLRLSTNAGQWK

Top

Potential FusionNeoAntigen Information of PTPRU-C10orf76 in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
PTPRU-C10orf76_29587415_103699695.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)
PTPRU-C10orf76chr129587415chr101036996951254HLA-B27:05SRTKCAVLR0.99790.7342817
PTPRU-C10orf76chr129587415chr101036996951254HLA-A30:08RTKCAVLRL0.99620.664918
PTPRU-C10orf76chr129587415chr101036996951254HLA-B08:01ISRTKCAVL0.98320.5537716
PTPRU-C10orf76chr129587415chr101036996951254HLA-B27:04SRTKCAVLRL0.99980.6745818
PTPRU-C10orf76chr129587415chr101036996951254HLA-C15:04RTKCAVLRL0.99890.767918
PTPRU-C10orf76chr129587415chr101036996951254HLA-C15:06RTKCAVLRL0.9960.7861918
PTPRU-C10orf76chr129587415chr101036996951254HLA-C15:09RTKCAVLRL0.99890.767918
PTPRU-C10orf76chr129587415chr101036996951254HLA-C15:02RTKCAVLRL0.99740.6744918
PTPRU-C10orf76chr129587415chr101036996951254HLA-A30:01RTKCAVLRL0.99620.8099918
PTPRU-C10orf76chr129587415chr101036996951254HLA-C15:05RTKCAVLRL0.99610.8354918
PTPRU-C10orf76chr129587415chr101036996951254HLA-B08:18ISRTKCAVL0.98320.5537716
PTPRU-C10orf76chr129587415chr101036996951254HLA-B27:06SRTKCAVLRL0.99960.6737818
PTPRU-C10orf76chr129587415chr101036996951254HLA-B27:09SRTKCAVLRL0.99960.7157818

Top

Potential FusionNeoAntigen Information of PTPRU-C10orf76 in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
PTPRU-C10orf76_29587415_103699695.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)
PTPRU-C10orf76chr129587415chr101036996951254DRB1-0415KCAVLRLSTNAGQWK1126
PTPRU-C10orf76chr129587415chr101036996951254DRB1-0436KCAVLRLSTNAGQWK1126
PTPRU-C10orf76chr129587415chr101036996951254DRB1-0453KCAVLRLSTNAGQWK1126

Top

Fusion breakpoint peptide structures of PTPRU-C10orf76

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
5125LISRTKCAVLRLSTPTPRUC10orf76chr129587415chr101036996951254

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of PTPRU-C10orf76

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score
HLA-B14:023BVN5125LISRTKCAVLRLST-8.15332-8.38852
HLA-B14:023BVN5125LISRTKCAVLRLST-4.04122-4.70312
HLA-B52:013W395125LISRTKCAVLRLST-6.88884-7.12404
HLA-B52:013W395125LISRTKCAVLRLST-4.8672-5.5291
HLA-A11:014UQ25125LISRTKCAVLRLST-6.14981-6.81171
HLA-A24:025HGA5125LISRTKCAVLRLST-8.34384-8.57904
HLA-A24:025HGA5125LISRTKCAVLRLST-6.84383-7.50573
HLA-B44:053DX85125LISRTKCAVLRLST-5.28202-5.94392
HLA-B44:053DX85125LISRTKCAVLRLST-4.34949-4.58469

Top

Vaccine Design for the FusionNeoAntigens of PTPRU-C10orf76

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence
PTPRU-C10orf76chr129587415chr10103699695716ISRTKCAVLGCCGCACCAAATGCGCAGTCCTGAGGC
PTPRU-C10orf76chr129587415chr10103699695817SRTKCAVLRGCACCAAATGCGCAGTCCTGAGGCTTT
PTPRU-C10orf76chr129587415chr10103699695818SRTKCAVLRLGCACCAAATGCGCAGTCCTGAGGCTTTCTA
PTPRU-C10orf76chr129587415chr10103699695918RTKCAVLRLCCAAATGCGCAGTCCTGAGGCTTTCTA

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence
PTPRU-C10orf76chr129587415chr101036996951126KCAVLRLSTNAGQWKGCGCAGTCCTGAGGCTTTCTACCAATGCAGGCCAGTGGAAGGAAG

Top

Information of the samples that have these potential fusion neoantigens of PTPRU-C10orf76

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample
STADPTPRU-C10orf76chr129587415ENST00000323874chr10103699695ENST00000370033TCGA-HU-A4GN-01A

Top

Potential target of CAR-T therapy development for PTPRU-C10orf76

check button Predicted 3D structure. We used RoseTTAFold.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result

Top

Related Drugs to PTPRU-C10orf76

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to PTPRU-C10orf76

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource